Dr. Marciscano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114
Education & Training
- National Cancer InstituteImmunotherapy, 2017 - 2018
- Johns Hopkins University School of MedicineRadiation Oncology, 2013 - 2017
- Massachusetts General HospitalInternal Medicine, 2012 - 2013
- New York University School of MedicineClass of 2012
Certifications & Licensure
- FL State Medical License 2022 - Present
- RI State Medical License 2023 - 2026
- MA State Medical License 2023 - 2025
- ME State Medical License 2023 - 2025
- NH State Medical License 2023 - 2025
- NJ State Medical License 2018 - 2025
- NY State Medical License 2018 - 2025
- American Board of Radiology Radiation Oncology
- Join now to see all
Publications & Presentations
PubMed
- 232 citationsConcurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.Linda Chen, Jacqueline Douglass, Lawrence Kleinberg, Xiaobu Ye, Ariel E. Marciscano
International Journal of Radiation Oncology, Biology, Physics. 2017-12-05 - 615 citationsLAG3 (CD223) as a cancer immunotherapy target.Lawrence P. Andrews, Ariel E. Marciscano, Charles G. Drake, Dario A. A. Vignali
Immunological Reviews. 2017-03-01 - 147 citationsStereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor MicroenvironmentYuki Muroyama, Thomas R. Nirschl, Christina M. Kochel, Zoila A. Lopez-Bujanda, Debebe Theodros
Cancer Immunology Research. 2017-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: